Acute mesenteric ischemia in patients with COVID-19: review of the literature
Open accessAbstract
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in a global health emergency. In addition to common respiratory symptoms, some patients with COVID-19 infections may experience a range of extra-pulmonary manifestations, such as digestive system involvement. Patients with COVID-19 have been reported to suffer from acute mesenteric ischemia (AMI) that is associated with disease-related severity and mortality. However, in the context of COVID-19, the exact cause of AMI has yet to be clearly defined. This review provides a comprehensive overview of the available data and elucidates the possible underlying mechanisms linking COVID-19 to AMI, in addition to highlighting therapeutic approaches for clinicians. Finally, given the severe global impact of COVID-19, we emphasize the importance of coordinated vaccination programs.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The typical presentation in patients with acute mesenteric ischemia is severe abdominal pain out of proportion to physical signs along with bowel emptying, nausea, vomiting and diarrhea that might progress into peritonitis and bowel perforation.
“The typical presentation in patients with acute mesenteric ischemia is severe abdominal pain that is out of proportion of physical signs along with bowel emptying, nausea, vomitimg and Diarrhea that might progress into peritonitis and bowel perforation [1, 2, 4, 5].”
From Outcome of Acute Mesenteric Ischemia in Patients with COVID 19 Infection Our Experience at Royal Medical Services (2022) · cites this paper as [1]
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredThromboembolic complications in association with severe COVID-19 pneumonic infection have been recognized more frequently, with acute mesenteric ischemia being one of the most devastating, accompanied by high morbidity with mortality rates reaching 60% to 80%.
“Thromboembolic complications, in association with severe COVID 19 pneumonic infection, has been recognized more frequenctly with acute mesenteric ischemia being one of the most devastating, accompanied by high morbidity with mortality rates reaching up to 60% to 80% among these patients [1-3].”
From Outcome of Acute Mesenteric Ischemia in Patients with COVID 19 Infection Our Experience at Royal Medical Services (2022) · cites this paper as [1]
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredThromboembolic complications have been reported increasingly during the COVID-19 pandemic, including acute mesenteric ischemia, which is a challenging and life-threatening condition accompanied by high rates of mortality and morbidity.
“However, Thromboembolic complications has been reported inceasingly during the corona virus pandemic, including acute mesenteric ischemia (AMI) which is a challenging and life threatening condition that is accompanied by high rates of mortality and morbidity [1, 2].”
From Outcome of Acute Mesenteric Ischemia in Patients with COVID 19 Infection Our Experience at Royal Medical Services (2022) · cites this paper as [1]
The Introduction describes elevated thromboembolic risk in COVID-19 patients and identifies AMI as a potential, sometimes fatal complication; it also reports mortality as high as 80% in untreated obstructive AMI. The Conclusions call AMI severe, life-threatening, and challenging to diagnose. The paper does not establish that reports of thromboembolic complications increased over the pandemic or state a high morbidity rate for AMI. (LLM, conf=0.82)
Experimental — accuracy not yet measuredThe primary cause of acute mesenteric ischemia is often acute blockage of the superior mesenteric artery, while emboli of cardiac origin lead to early onset symptoms including poorly localized stomach discomfort.
“The primary cause of AMI is often the acute blockage of the superior mesenteric artery (SMA) while emboli of cardiac origin lead to early onset symptoms, including poorly localized stomach discomfort [13,14].”
From Outcomes of Acute Mesenteric Ischemia in Patients With COVID-19: A Nationwide Database Study (2023) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 52 · Cited by 14
- Authors
- Chen, C., Li, Y.-W., Shi, P.-F., & Qian, S.-X.
- Affiliations
- Zhejiang University (CN)
- Venue
- Journal of the National Medical Association
- Publisher
- Elsevier BV
- Published
- 2022-02
- Volume
- 114
- Issue
- 1
- Pages
- 47-55
- ISSN
- 0027-9684 (ISSN-L)
- PMC
- PMC8715336
- OpenAlex
- W4200029598
- Cited by
- 14
- References
- 52
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 3 · 2022: 8
- FWCI
- 0.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of the National Medical Association (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Abdominal vascular conditions and treatments
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Ophthalmology › Retinal and Optic Conditions
- Keywords
- acute mesenteric ischemia, COVID-19 pandemic, SARS-CoV-2, extrapulmonary manifestations, gastrointestinal involvement, pathogenesis, mortality, treatment, COVID-19 vaccination
- MeSH terms
- COVID-19, SARS-CoV-2, Humans, Lung, Pandemics, Mesenteric Ischemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
